Lavin Michael R MD - Binghamton, New York 13905

Lavin Michael R MD is categorized under Doctors in Binghamton, NY .

Business Name: Lavin Michael R MD
Contact Person: Michael Lavin
Address: 303 Main St # 1, Binghamton, New York 13905
Phone Number: (607) 584-4465
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Singh Vaibhav K MD - Binghamton, NY 13905
Kass Martin MD - Binghamton, NY 13905
Mikloucich Cori L DO - Binghamton, NY 13905
Gawel Marek MD - Binghamton, NY 13905
Uppal Paul MD - Binghamton, NY 13905
Malick Omar MD - Binghamton, NY 13905
Eastman-Abaya Robin MD - Binghamton, NY 13905
Wu Richard H K MD - Binghamton, NY 13905
Yu Hong MD - Binghamton, NY 13905
Gray Elisabeth M MD - Binghamton, NY 13905
Bishop Laura J MD - Binghamton, NY 13905
Helen P Papastrat - Binghamton, NY 13905
Declan F O'riordan Md Pc - Binghamton, NY 13905
Rao Mukesh MD - Binghamton, NY 13905
Payes William C MD - Binghamton, NY 13905
Lerman Alan S MD - Binghamton, NY 13905
Dreyfuss David C MD - Binghamton, NY 13905
Galu Maria G MD - Binghamton, NY 13905
Farrell Michael A MD - Binghamton, NY 13905
Bautista Aurora MD - Binghamton, NY 13905

The company Lavin Michael R MD provides B2C services in the form of Doctors from its single location in New York. 1 to 4 employees work for Lavin Michael R MD, and the business now earns $500.000 to $999.999 per annum.

Lavin Michael R MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Lavin Michael R MD, please call Michael Lavin with the phone number (607) 584-4465 or visit its single location at 303 Main St # 1 in Binghamton, New York 13905.

The location of the single location can also be found using the coordinates 42.10938,-75.9415. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.